医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Lianhua Qingwen Capsules Launched in Philippine Market

2020年12月01日 PM12:00
このエントリーをはてなブックマークに追加


 

SHIJIAZHUANG CITY, China

On November 23 local time, the news conference for launching of Lianhua Qingwen Capsules, a Chinese traditional medicine produced by Yiling Pharmaceutical, was held online. It signifies that Lianhua Qingwen has officially come into the Philippine market for sale, providing the nation with a traditional Chinese medicine (TCM) solution for respiratory diseases including COVID-19, cold and flu.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005420/en/

The FDA approved packaging comes with an English text, indicating the generic names of all the 13 herbs in the formula. (Photo: Business Wire)

The FDA approved packaging comes with an English text, indicating the generic names of all the 13 herbs in the formula. (Photo: Business Wire)

Zhang Yunling, the standing deputy general manager of Yiling Pharmaceutical, said “three drugs and three prescriptions”, the effective medicines screened out clinically, have played an important role in COVID-19 prevention and control in China and even in the world. As the representative of “three drugs and three prescriptions”, Lianhua Qingwen has been the most recommended by Chinese authorities and local authorities for the treatment of COVID-19.

Olivia Limpe Aw, the Philippine agent of Lianhua Qingwen Capsules and chairman of Philippine Islands International Trading Corporation, announced in the news conference that the outbreak of COVID-19 has shown people the unique advantages of TCM, as the first traditional Chinese medicine that has obtained approval in the Philippines, its launch will help Filipinos a lot. “People always say ‘it’s better late than never’, TCM is safe and effective and with low price. It is the hope for us to beat COVID-19”.

In the news conference, Dr. Wei Cong, president of TCM Branch of Hebei Yiling Pharmaceutical Research Institute, gave a themed lecture named “From SARS to COVID-19 — The path of Yiling Pharmaceutical using TCM to fight against epidemics”, in which she explained the effect of Lianhua Qingwen Capsules on previous respiratory infectious diseases such as SARS, H1N1 flu, MERS.

Dr. Philip Tan Gatue, TCM expert from the Philippines, also gave a lecture focused on topics such as TCM theory, formula mechanism, and ancient famous prescriptions. “It can help us adapt TCM to modern use, preventing and treating new diseases by understanding the mechanism of ancient Chinese medicine formulas. TCM and Western medicine supplementing each other is a major trend of medical development in the future”, he said.

According to Olivia Limpe Aw, the Filipinos now can buy Lianhua Qingwen Capsules at South Star Drug, one of the largest chain drugstores, Watsons and Mercury Drug.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201130005420/en/

CONTACT

First Name: Li

Last Name: Kristy

E-mail: kristyli@chuhaimedia.com.cn

Phone No.: +86 57731448

同じカテゴリーの記事 

  • LC-Plasma-based Vaccine Research Selected for SCARDA Project
  • 一份具有里程碑意义的报告证明,大量使用尼古丁不会导致健康问题高发
  • Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD)
  • Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries
  • Inocras Hong Kong Limited, in Collaboration with Cancerinformation.com.hk Charity Foundation and Sponsored by AstraZeneca Hong Kong, Offers Free BRCA or HRD Genetic Testing for Eligible Cancer Patients in Hong Kong and Macau